Scholarlink

<p>We developed an effective nanoplatform, <sub>T+EP</sub>AuNP<sub>Lu&amp;Lap</sub>, that concurrently harnesses Type I photodynamic therapy (PDT), chemodynamic therapy (CDT), photothermal therapy (PTT), and immunomodulation to remodel the immunosuppressive tumor microenvironment (TME). By pairing PpIX and EGCG, the system enables the transformation of PpIX from Type II PDT to oxygen-independent Type I for superoxide (O<sub>2</sub>•<sup>–</sup>) generation, courtesy of electron-richness and low reduction potential of EGCG. Mn<sup>2+</sup>-mediated Fenton-like reaction produces hydroxyl radicals (•OH) for CDT, while its superoxide dismutase (SOD) activity alleviates tumor hypoxia. β-Lapachone-triggered H<sub>2</sub>O<sub>2</sub> elevation augments luminol chemiluminescence, which not merely fortifies CDT, but also induces bio-orthogonal tetrazole-PpIX click reaction, driving AuNP aggregation for deep-tissue PTT without the need of external light. EGCG-mediated mitochondrial targeting intensifies mitochondrial oxidative and thermal stress, further amplified by EQ-driven GSH depletion. This causes ATP depletion, HSP70 downregulation, ICD, and mtDNA release, which activates the cGAS-STING-PERK pathway, promotes ER stress and antitumor immunity, and inhibits lung metastasis. Collectively, this multimodal nanoplatform remodels TME into a hypoxia-alleviated, M1 macrophage-rich, and Treg-suppressed proinflammatory state, achieving efficacious eradication of tumor and inhibition of pulmonary metastasis in vivo.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Self-supplying hydrogen peroxide-driven gold nanoparticle aggregation via bio-orthogonal click reaction activates cGAS-STING-PERK pathway for multimodal tumor therapy

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月27日

查看全文
  • Junyou LI,
  • Kaiqi Hu,
  • Man Lung Lee,
  • Ting Li,
  • Pinyou Chen,
  • Chengke Wang,
  • Hung-Wing LI

摘要

We developed an effective nanoplatform, T+EPAuNPLu&Lap, that concurrently harnesses Type I photodynamic therapy (PDT), chemodynamic therapy (CDT), photothermal therapy (PTT), and immunomodulation to remodel the immunosuppressive tumor microenvironment (TME). By pairing PpIX and EGCG, the system enables the transformation of PpIX from Type II PDT to oxygen-independent Type I for superoxide (O2•–) generation, courtesy of electron-richness and low reduction potential of EGCG. Mn2+-mediated Fenton-like reaction produces hydroxyl radicals (•OH) for CDT, while its superoxide dismutase (SOD) activity alleviates tumor hypoxia. β-Lapachone-triggered H2O2 elevation augments luminol chemiluminescence, which not merely fortifies CDT, but also induces bio-orthogonal tetrazole-PpIX click reaction, driving AuNP aggregation for deep-tissue PTT without the need of external light. EGCG-mediated mitochondrial targeting intensifies mitochondrial oxidative and thermal stress, further amplified by EQ-driven GSH depletion. This causes ATP depletion, HSP70 downregulation, ICD, and mtDNA release, which activates the cGAS-STING-PERK pathway, promotes ER stress and antitumor immunity, and inhibits lung metastasis. Collectively, this multimodal nanoplatform remodels TME into a hypoxia-alleviated, M1 macrophage-rich, and Treg-suppressed proinflammatory state, achieving efficacious eradication of tumor and inhibition of pulmonary metastasis in vivo.

Graphical Abstract